-
Loading metrics
SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans
- Clare F. Price,
- David Tyssen,
- Secondo Sonza,
- Ashley Davie,
- Sonya Evans,
- Gareth R. Lewis,
- Shirley Xia,
- Tim Spelman,
- Peter Hodsman,
- Thomas R. Moench
x
- Published: September 15, 2011
- https://doi.org/10.1371/journal.pone.0024095